Toxic Methemoglobinemia Treated with Ascorbic Acid: Case report | Zendy

Hatice Topal | Zendy; Yaşar Topal | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Toxic Methemoglobinemia Treated with Ascorbic Acid: Case report

Author(s) -

Hatice Topal,

Yaşar Topal

Publication year - 2013

Publication title -

iranian red crescent medical journal

Language(s) - English

Resource type - Journals

eISSN - 2074-1812

pISSN - 2074-1804

DOI - 10.5812/ircmj.12718

Subject(s) - methemoglobinemia , ascorbic acid , methylene blue , medicine , methemoglobin , prilocaine , pharmacology , surgery , anesthesia , biochemistry , food science , chemistry , hemoglobin , photocatalysis , catalysis , lidocaine

Methemoglobinemia is a disorder characterized by the presence of a higher than normal level of methemoglobin. Prilocaine which is one of the oxidizing local anaesthetics is widely used in many local procedures. The first choice of treatment of complications due to the use of these local anaesthetics is methylene blue, while ascorbic acid is the alternative choice. The side effects of metilen blue restrict its usage in some special conditions. Ascorbic acid is a good alternative drug with limited experience in methemoglobinemia. We present a case of a methemoglobinemia treated with ascorbic acid successfully to emphasize the use of ascorbic acid as an alternative method.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research